Sperna Weiland, Christina J.
Akshintala, Venkata S.
Singh, Anmol
Buxbaum, James
Choi, Jun-Ho
Elmunzer, Badih J.
Fogel, Evan S.
Lai, Jian-Han
Levenick, John M.
Gardner, Timothy B.
Lua, Guan W.
Luo, Hui
de Jong, Mike
Mok, Shaffer R. S.
Phillip, Veit
Singh, Vikesh
Siersema, Peter D.
Drenth, Joost P. H.
van Geenen, Erwin J. M.
Article History
Received: 30 July 2024
Accepted: 10 October 2024
First Online: 5 November 2024
Declarations
:
: JPHD has received research funding from Gilead and Abbvie. EJMvG has received research funding from Boston Scientific, Micro-Tech, Pentax, Tae Woong, Olympus, Viatris, and Zambon Medical and served as a consultant for MTW-Endoskopie. PS has received research funding from Pentax, Boston Scientific, Micro-Tech, and The Enose Company. VK reports personal fees from Abbvie, is an advisory board participant for Cook Medical, and receives grants from Orgensis and Theraly. VSA is co-founder and chief medical officer of Origin Endoscopy Inc., Solv Endotherapy Inc. and consultant for Olympus and has received educational grants from Boston Scientific, Medtronic, Abbvie, and Chirhoclin. All other authors declare no competing interests.
: N/A.
: N/A.
: PROSPERO: registration number CRD42021231197.
: N/A.